Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are prioritized for R&D in public health emergency contexts.
An allergy doctor says vaccine reaction risk is extremely low and the chances are greater that someone would have a bad outcome from COVID-19. (Dec. 17)
AP Domestic
